Experience in IVIg therapy for selected women with recurrent reproductive failure and NK cell expansion

American Journal of Reproductive Immunology

Volumn 71, Issue 5, 2014, Pages 458-466

  Ramos Medina, Rocio ^a   García Segovia, Aurea ^b   Gil, Juana ^a   Carbone, Javier ^a   Aguarón de la Cruz, Angel ^a   Seyfferth, Ansgar ^c   Alonso, Bárbara ^a   Alonso, Jorge ^b   León, Juan A ^a   Alecsandru, Diana ^a   Meliá, Elena ^d   Carrillo de Albornoz, Elena ^d   Ordoñez, Daniel ^d   Santillán, Isabel ^e   Verdú, Victoria ^e   Garcia Ruiz de Morales, Jose Maria ^f   López Hoyos, Marcos ^g   López Larios, Arturo ^a,h   Sampalo, Almudena ^g,i   Caballero, Pedro ^b   Ortiz Quintana, Luis ^a   Fernández Cruz, Eduardo ^a   Sánchez Ramón, Silvia ^a   more..

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^b Clinica Tambre   (Spain)

^c STAT UP Statistical Consulting and Services   (Spain)

^d HOSPITAL RUBER INTERNACIONAL   (Spain)

^e Grupo de Interés de Salud Embrionaria   (Spain)

^f HOSPITAL UNIVERSITARIO DE LEÓN   (Spain)

^g HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^h HOSPITAL CLÍNICO SAN CARLOS   (Spain)

ⁱ HOSPITAL UNIVERSITARIO PUERTA DEL MAR   (Spain)

Author keywords

IVIg therapy; Natural killer cells; Observational study; Recurrent reproductive failure

Indexed keywords

IMMUNOGLOBULIN; IMMUNOLOGIC FACTOR;

ABORTION, HABITUAL; ADULT; DRUG EFFECTS; FEMALE; FERTILIZATION IN VITRO; HUMAN; IMMUNOLOGY; LIVE BIRTH; LYMPHOCYTE COUNT; NATURAL KILLER CELL; NATURAL KILLER T CELL; PATHOLOGY; PREGNANCY; STATISTICAL MODEL; TREATMENT FAILURE;

ABORTION, HABITUAL; ADULT; FEMALE; FERTILIZATION IN VITRO; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOLOGIC FACTORS; KILLER CELLS, NATURAL; LIVE BIRTH; LOGISTIC MODELS; LYMPHOCYTE COUNT; NATURAL KILLER T-CELLS; PREGNANCY; TREATMENT FAILURE;

EID: 84898803914     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/aji.12217     Document Type: Article

References (37)

1. Makrigiannakis A, Petsas G, Toth B, Relakis K, Jeschke U: Recent advances in understanding immunology of reproductive failure. J Reprod Immunol 2011; 90:96-104.
2. Patel RN, Quack KC, Hill JA, Schust DJ: Expression of membrane-bound HLA-G at the maternal-fetal interface is not associated with pregnancy maintenance among patients with idiopathic recurrent pregnancy loss. Mol Hum Reprod 2003; 9:551-557.
3. Regan L, RAI R: The Investigation and Treatment of Couples with Recurrent First-trimester and Second-trimester Miscarriage. London, Royal College of Obstetricians and Gynaecologists, 2011.
4. Margalioth EJ, Ben-Chetrit A, Gal M, Eldar-Geva T: Investigation and treatment of repeated implantation failure following IVF-ET. Hum Reprod 2006; 21:3036-3043.
5. De Carolis C, Perricone C, Perricone R: NK cells, autoantibodies, and immunologic infertility: a complex interplay. Clin Rev Allergy Immunol 2010; 39:166-175.
6. Ford HB, Schust DJ: Recurrent pregnancy loss: etiology, diagnosis, and therapy. Rev Obstet Gynecol 2009; 2:76-83.
7. Karami N, Boroujerdnia MG, Nikbakht R, Khodadadi A: Enhancement of peripheral blood CD56(dim) cell and NK cell cytotoxicity in women with recurrent spontaneous abortion or in vitro fertilization failure. J Reprod Immunol 2012; 95:87-92.
8. Ramos-Medina R, García-Segovia Á, León JA, Alonso B, Tejera-Alhambra M, Gil J, Caputo JD, Seyfferth A, Aguarón Á, Vicente Á, Ordoñez D, Alonso J, de Albornoz EC, Carbone J, Caballero P, Fernandez-Cruz E, Ortiz-Quintana L, Sánchez-Ramón S: New decision-tree model for defining the risk of Reproductive Failure. Am J Reprod Immunol 2013; 70:59-68.
9. Beer AE, Kwak JY, Ruiz JE: Immunophenotypic profiles of peripheral blood lymphocytes in women with recurrent pregnancy losses and in infertile women with multiple failed in vitro fertilization cycles. Am J Reprod Immunol 1996; 35:376-382.
10. Yamada H, Morikawa M, Kato EH, Shimada S, Kobashi G, Minakami H: Pre-conceptional natural killer cell activity and percentage as predictors of biochemical pregnancy and spontaneous abortion with normal chromosome karyotype. Am J Reprod Immunol 2003; 50:351-354.
11. Fukui A, Funamizu A, Yokota M, Yamada K, Nakamua R, Fukuhara R, Kimura H, Mizunuma H: Uterine and circulating natural killer cells and their roles in women with recurrent pregnancy loss, implantation failure and preeclampsia. J Reprod Immunol 2011; 90:105-110.
12. Graphou O, Chioti A, Pantazi A, Tsukoura C, Kontopoulou V, Guorgiadou E, Balafoutas C, Koussoulakos S, Margaritis LH, Varla-Leftherioti M: Effect of intravenous immunoglobulin treatment on the Th1/Th2 balance in women with recurrent spontaneous abortions. Am J Reprod Immunol 2003; 49:21-29.
13. Coulam CB, Krysa LW, Bustillo M: Intravenous immunoglobulin for in-vitro fertilization failure. Hum Reprod 1994; 9:2265-2269.
14. Ata B, Tan SL, Shehata F, Holzer H, Buckett W: A systematic review of intravenous immunoglobulin for treatment of unexplained recurrent miscarriage. Fertil Steril 2011; 95(1080-5):e1-e2.
15. Tang AW, Alfirevic Z, Quenby S: Natural killer cells and pregnancy outcomes in women with recurrent miscarriage and infertility: a systematic review. Hum Reprod 2011; 26:1971-1980.
16. Kwak-Kim J, Yang KM, Gilman-Sachs A: Recurrent pregnancy loss: a disease of inflammation and coagulation. J Obstet Gynaecol Res 2009; 35:609-622.
17. Ruiz JE, Kwak JY, Baum L, Gilman-Sachs A, Beaman KD, Kim YB, Beer AE: Effect of intravenous immunoglobulin G on natural killer cell cytotoxicity in vitro in women with recurrent spontaneous abortion. J Reprod Immunol 1996; 31:125-141.
18. Perricone R, Di Muzio G, Perricone C, Giacomelli R, De Nardo D, Fontana L, De Carolis C: High levels of peripheral blood NK cells in women suffering from recurrent spontaneous abortion are reverted from high-dose intravenous immunoglobulins. Am J Reprod Immunol 2006; 55:232-239.
19. Shimada S, Takeda M, Nishihira J, Kaneuchi M, Sakuragi N, Minakami H, Yamada H: A high dose of intravenous immunoglobulin increases CD94 expression on natural killer cells in women with recurrent spontaneous abortion. Am J Reprod Immunol 2009; 62:301-307.
20. Heilmann L, Schorsch M, Hahn T: CD3-CD56 + CD16 + natural killer cells and improvement of pregnancy outcome in IVF/ICSI failure after additional IVIG-treatment. Am J Reprod Immunol 2010; 63:263-265.
21. van den Heuvel MJ, Peralta CG, Hatta K, Han VK, Clark DA: Decline in number of elevated blood CD3(+) CD56(+) NKT cells in response to intravenous immunoglobulin treatment correlates with successful pregnancy. Am J Reprod Immunol 2007; 58:447-459.
22. Stricker RB, Winger EE: Update on treatment of immunologic abortion with low-dose intravenous immunoglobulin. Am J Reprod Immunol 2005; 54:390-396.
23. Winger EE, Reed JL, Ashoush S, El-Toukhy T, Ahuja S, Taranissi M: Elevated preconception CD56+ 16+ and/or Th1:Th2 levels predict benefit from IVIG therapy in subfertile women undergoing IVF. Am J Reprod Immunol 2011; 66:394-403.
24. Hammarstrom L, Smith CI: Placental transfer of intravenous immunoglobulin. Lancet 1986; 1:681.
25. Palmeira P, Quinello C, Silveira-Lessa AL, Zago CA, Carneiro-Sampaio M: IgG placental transfer in healthy and pathological pregnancies. Clin Dev Immunol 2012; 2012:985646.
26. Gardulf A, Andersson E, Lindqvist M, Hansen S, Gustafson R: Rapid subcutaneous IgG replacement therapy at home for pregnant immunodeficient women. J Clin Immunol 2001; 21:150-154.
27. Kwak JY, Kwak FM, Ainbinder SW, Ruiz AM, Beer AE: Elevated peripheral blood natural killer cells are effectively downregulated by immunoglobulin G infusion in women with recurrent spontaneous abortions. Am J Reprod Immunol 1996; 35:363-369.
28. Coulam CB, Acacio B: Does immunotherapy for treatment of reproductive failure enhance live births? Am J Reprod Immunol 2012; 67:296-304.
29. Moraru M, Carbone J, Alecsandru D, Castillo-Rama M, García-Segovia A, Gil J, Alonso B, Aguarón A, Ramos-Medina R, Martínez de María J, Oliver-Miñarro D, Rodríguez-Mahou M, Ortega V, Caballero P, Meliá E, Vidal J, Cianchetta-Sivori M, Esteban C, Vargas-Henny L, Dale J, Ortiz-Quintana L, Fernández-Cruz E, Sánchez-Ramón S: Intravenous immunoglobulin treatment increased live birth rate in a Spanish cohort of women with recurrent reproductive failure and expanded CD56(+) cells. Am J Reprod Immunol 2012; 68:75-84.
30. Coulam CB, Krysa L, Stern JJ, Bustillo M: Intravenous immunoglobulin for treatment of recurrent pregnancy loss. Am J Reprod Immunol 1995; 34:333-337.
31. Hutton B, Sharma R, Fergusson D, Tinmouth A, Hebert P, Jamieson J, Walker M: Use of intravenous immunoglobulin for treatment of recurrent miscarriage: a systematic review. BJOG 2007; 114:134-142.
32. Porter TF, LaCoursiere Y, Scott JR.: Immunotherapy for recurrent miscarriage. Cochrane Database Syst Rev 2006; (2):CD000112.
33. Stephenson MD, Kutteh WH, Purkiss S, et al.: Intravenous immunoglobulin and idiopathic secondary recurrent miscarriage: a multicentered randomized placebo-controlled trial. Hum Reprod 2010; 25:2203-2209.
34. Jablonowska B, Selbing A, PalfiM, Ernerudh J, Kjellberg S, Lindton B: Prevention of recurrent spontaneous abortion by intravenous immunoglobulin: a double-blind placebo-controlled study. Hum Reprod 1999; 14:838-841.
35. Bansal AS, Bajardeen B, Thum MY: The basis and value of currently used immunomodulatory therapies in recurrent miscarriage. J Reprod Immunol 2012; 93:41-51.
36. Clark DA, Coulam CB, Stricker RB: Is intravenous immunoglobulins (IVIG) efficacious in early pregnancy failure? A critical review and meta-analysis for patients who fail in vitro fertilization and embryo transfer (IVF). J Assist Reprod Genet 2006; 23:1-13.
37. Libro Blanco Sociosanitario: La infertilidad en España, situación actual y perspectivas. Madrid. R Matorras Weinig (ed.). Coeditors: Coroleu Lletget B, Romeu Sarrió A, Pérez Milán E. 2011.